Jens Biertumpel

Jens Biertumpel is a declared insider of bioMmune Technologies Inc., with filings sourced from SEDI. We count 5 filings; the first trade dates from 22 January 2016 and the latest from 22 April 2016.

The open-market record is one-sided, with 5 purchases and not one sale. The totals exclude 5 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Most recently, on 22 April 2016, the filings show an open-market purchase in bioMmune Technologies Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.